
Maxim Sevostyanov
Director of Global Regulatory and Medical Translations
Education:
2015—2019 — Manash Kozybayev
North Kazakhstan University

gaukhar bilimbayeva
Chief Executive Officer (CEO), PharmD, MBA
Education:
1997—2002 — S. Asfendiyarov Kazakh National Medical University
2016—2018 — MBA, Swiss Business School, Zurich, Switzerland

dauren bilimbayev
Founder
Education:
2000—2004 — T. Ryskulov Kazakh Economic University
2003—2005 — S. Amanzholov East Kazakhstan State University
2016—2017 — NIMA International Marketing School, the Netherlands

Anna polivoda
Deputy CEO, Head
of Sales and Marketing
Education:
2018—2022 — Almaty Management University (AlmaU)
2022—2024 — Sh. Murtaza International University

gulzhan akhmetova
Head of Registration Department,
Quality Responsible Person
Education:
2005—2009 — Al-Farabi Kazakh National University
2013—2015 — K. I. Satpayev Kazakh National Technical University (KazNTU)

Bulegenova Zhadyra
Senior Registration Specialist
Education:
2008-2012 — Al-Farabi Kazakh National University (Bachelor's)
2012-2014 — S. Asfendiyarov Kazakh National Medical University (Master's)

Jenis Kamila
Registration Specialist
Education:
2016-2020 — S. Asfendiyarov Kazakh National Medical University

Asel Seidakhmetova
Senior Registration Specialist
Education:
2006-2010 — Kazakh National Agrarian University (KazNAU)





















Preparation of the dossier, reference standards and samples takes from 1 to 12 months. The statutory registration timeline is 150 calendar days excluding clock-stops, and each submission of additional documents extends the examination by 10 calendar days.
The registration dossier is compiled in CTD format in Armenian, Russian or English. In addition, the documentation is translated into Armenian as part of the preparation of local documents.
The results of the examination are reviewed by the Pharmacological Council of the Ministry of Health. The final stage is the order of the Ministry of Health of the Republic of Armenia on registration and the issuance of the marketing authorization.
Yes, refusal on this ground is listed among the common registration risks in Armenia. Therefore, before submission, Registrarius Pharm Expert assesses the regulatory status of the product and selects the appropriate procedure.
To meet the requirements of the Armenian regulator, the quality specification (normative quality document), the summary of product characteristics and the patient information leaflet are developed, the documentation is translated into Armenian, and dossier sections are certified.